DEUTSCHE BANK AG\ - DIAMEDICA THERAPEUTICS INC ownership

DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 15 filers reported holding DIAMEDICA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of DIAMEDICA THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$2,000551
+3141.2%
0.00%
Q4 2019$0170.00%
Other shareholders
DIAMEDICA THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Manatuck Hill Partners, LLC 267,300$1,326,0000.62%
Worth Venture Partners, LLC 132,514$657,0000.36%
WEXFORD CAPITAL LP 400,000$1,984,0000.23%
Eidelman Virant Capital 35,000$173,0000.09%
Granite Point Capital Management, L.P. 229,970$1,141,0000.08%
Patriot Financial Group Insurance Agency, LLC 2,000$10,0000.00%
GABLES CAPITAL MANAGEMENT INC. 125$1,0000.00%
FNY Investment Advisers, LLC 521$2,0000.00%
MILLENNIUM MANAGEMENT LLC 99,340$493,0000.00%
TORONTO DOMINION BANK 48$00.00%
View complete list of DIAMEDICA THERAPEUTICS INC shareholders